Caina Technology Co., Ltd. (SHE:301122)

Market Cap	6.14B +89.4%
Revenue (ttm)	551.29M +61.4%
Net Income	13.55M +248.1%
EPS	0.12 +256.5%
Shares Out	122.25M
PE Ratio	434.77
Forward PE	70.69
Dividend	0.04 (0.08%)
Ex-Dividend Date	Jun 9, 2026

Volume	4,498,900
Open	56.30
Previous Close	53.53
Day's Range	50.16 - 56.30
52-Week Range	23.00 - 71.74
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About Caina Technology

Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,057
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301122

Financial Performance

In 2025, Caina Technology's revenue was 356.69 million, a decrease of -8.04% compared to the previous year's 387.89 million. Earnings were 5.62 million, a decrease of -89.41%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 27, 2026

Data Sources Report a data error